Transforming Industries: Announcing the Foresight 50, Canada's Most Investible Cleantech Companies GlobeNewswire November 05, 2025 CALGARY, Alberta, Nov. 05, 2025 (GLOBE NEWSWIRE) — Canadian cleantech is rapidly reaching market maturity, with many market-ready solutions deploying, becoming profitable, and solving real-world challenges for industry leaders across the country, and the world. Last night in Calgary, the […]

Easy Renovation Study Reveals Toronto's Top Kitchen Renovation Companies in 2025 GlobeNewswire November 05, 2025 Toronto, Ontario, Nov. 05, 2025 (GLOBE NEWSWIRE) — Easy Renovation, a Toronto-based design and renovation company, has released a new study identifying the 10 best kitchen renovation companies in Toronto for 2025, helping homeowners make informed choices when planning their

(TSX:CGI),(LSE:CGI), TORONTO, Canada, Nov. 05, 2025 (GLOBE NEWSWIRE) — Canadian General Investments, Limited (CGI) (TSX:CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at October 31, 2025 was $82.06 resulting in year-to-date and 12-month NAV returns, with dividends reinvested, of 19.8% and 25.4%, respectively. These compare with the

Canadian General Investments: Investment Update – Unaudited GlobeNewswire November 05, 2025 TORONTO, Canada, Nov. 05, 2025 (GLOBE NEWSWIRE) — Canadian General Investments, Limited (CGI) (TSX:CGI) (LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at October 31, 2025 was $82.06 resulting in year-to-date and 12-month NAV returns, with dividends

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Tvardi Therapeutics, Inc. ("Tvardi Therapeutics, Inc.") (NASDAQ:TVRD) concerning possible violations of federal securities laws. On October 13, 2025, Tvardi reported data from its Phase 2 REVERT study testing its STAT3 inhibitor drug,

PALO ALTO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Denodo, a leader in data management, announced that it has been placed as a top vendor in the 2025 Active Data Architecture(TM) report from Dresner Advisory Services. Dresner defines an “Active Data Architecture(TM)” as that which “supports a platform-independent layer that sits between physical data stores

Denodo Recognized as Top Vendor in the Dresner Advisory Active Data Architecture(TM) Report, for Second Time in a Row In 2024 and 2025, Denodo Ranked as a Leading Technology Provider for Active Data Architecture, Leveraging Logical Data Management Capabilities GlobeNewswire November 05, 2025 PALO ALTO, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) — Denodo, a leader

(NYSE:PLX), LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. (“Protalix” or “the Company”) (NYSE: PLX) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or

PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm GlobeNewswire November 05, 2025 LOS ANGELES, Nov. 05, 2025 (GLOBE NEWSWIRE) — The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Protalix BioTherapeutics, Inc. (“Protalix” or “the

NEW YORK, NY / ACCESS Newswire / November 5, 2025 / If you suffered a loss on your James Hardie Industries plc. (NYSE:JHX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/james-hardie-industries-plc-lawsuit-submission-form?prid=175683&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com